The Drew Weissman Lab
@WeissmanLab
Followers
9K
Following
3K
Media
75
Statuses
685
Bringing mRNA therapeutics to the world. https://t.co/R5OvtnUHwb
University of Pennsylvania
Joined January 2021
I talked to @DrPaulOffit, Nobel-winning MRNA inventor @WeissmanLab & CHOP's Charlotte Moser about Philadelphia’s imperiled medical research ecosystem: https://t.co/t5NBFqoVWh via @CityAndStatePA @ChildrensPhila @CHOP_Research
cityandstatepa.com
Amid federal defunding of scientific research and radical shifts in vaccine and health policy, City & State surveyed Philadelphia’s top vaccine experts to discuss what’s at stake.
0
1
0
Dr. Weissman discussed the role of mRNA-LNP for cancer treatment & autoimmunity He concluded with a call to action: equitable IP access and capacity building for vaccines and therapeutics in LMICs, addressing diseases that disproportionately affect these regions @WeissmanLab
0
1
4
🎉Our newest pre-print is now online on bioRxiv! Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis @JilianMelamed @weissmanlab
biorxiv.org
The modularity of mRNA-lipid nanoparticle (mRNA-LNP) platforms has enabled their rapid adaptation from infectious disease vaccines to emerging applications in immune-mediated disorders. However,...
0
0
5
Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases https://t.co/2ZFjIjTv99
#MTMCD
cell.com
This review describes the development of RNA-lipid nanoparticle therapies for autoimmune disease. It highlights the importance of creating targeted, non-inflammatory lipid nanoparticles and explores...
0
9
37
Robert F. Kennedy Jr announced that the US federal government is terminating US$500 million worth of grants for mRNA vaccine research. We must never, ever, forget that millions are alive today, or in better health, because of this life-saving technology. https://t.co/Y6HIzyQ8Qj
nature.com
Nature - The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the world out of the COVID-19 pandemic.
59
289
747
#ICYMI: Registration is now open for Cores Day on Thursday, September 11th!🥳🎉 @PennMedicine @ChildrensPhila @PennVet @TheWistar -Free registration➡️ https://t.co/8FbqkQtGFf -Event website➡️ https://t.co/VfOKUbHki0
0
2
3
ft. Ningqiang Gong, @DongyoonKim5, @_emilyhan_, @rohan_palanki, @ShiQiangqiang, @Xuexiang_Han, @Lulu_Xuee, @Junchao_online, Christian Figueroa-Espada, @MJMitchell_Lab (@pennbioeng), @MgAlameh, @Rakan_ElMayta, Garima Dwivedi & @WeissmanLab (@PennMedicine) https://t.co/JK5Gc8HCvU
0
1
1
Calling all BGS alumni - come celebrate 40 years of BGS with us this fall, as we bring together alumni, students, and faculty to revisit where we've been and make new, lasting connections. We can't wait to welcome you back to campus! Register here: https://t.co/u8G4xsxhaw
0
6
8
Fewer side-effects, more effectiveness. @MJMitchell_Lab's lab redesigned mRNA lipid nanoparticles using olive oil-inspired chemistry. Adding phenol groups reduces inflammation, making mRNA therapies safer & more effective. "It's a win-win," says Mitchell.
2
7
30
RNA chemistry and therapeutics, an exciting and impactful review article in collaboration with Dr. Drew Weissman! @WeissmanLab
https://t.co/Zh8fv85y70
https://t.co/E6t7aAOfrn
nature.com
Nature Reviews Drug Discovery - Chemical modification represents an effective strategy to improve the stability, efficiency and specificity of RNA therapeutics, while reducing their immunogenicity....
3
11
73
Red Ribbon Connect links Penn with HIV/AIDS researchers worldwide
penntoday.upenn.edu
Organized by a recent Penn alum on the Community Advisory Board of the Penn Center for AIDS Research, the newly launched Red Ribbon Connect program entails a monthly virtual exchange for HIV/AIDS...
1
0
1
“Estoy muy honrado de estar hoy aquí, de ser un invitado y esperemos que un próximo colaborador de esta Universidad”, Dr. Drew Weissman @WeissmanLab, ganador del Premio Nobel de Medicina 2023, durante su visita a la FacMed.
1
1
8
🔬 Acompañamos al Dr. David Kershenobich, secretario de Salud del Gobierno de México, en un encuentro con el Dr. Drew Weissman, Premio Nobel de Medicina 2023. Dialogamos sobre innovación científica y su importancia para afrontar los retos en la atención médica. Desde @Tu_IMSS
0
29
68
Penn Engineers Turn Toxic Fungus into Anti-Cancer Drug
blog.seas.upenn.edu
Penn-led researchers have turned a deadly fungus into a potent cancer-fighting compound. After isolating a new class of molecules from Aspergillus flavus, a toxic crop … Read More ›
0
1
2
New in @SciImmunology! @EmilyAunins, Dr. Anthony Phan, and their colleagues in the @WeissmanLab and Hunter Lab (@KingOfPathogens) used lipid nanoparticles encoding IL-12 to boost CD8 T cell responses to mRNA vaccines. 📃 https://t.co/0chkzWVDqm 🎧 https://t.co/vvDVzU06M6
0
3
8
Improving T-cell responses to vaccines ft. @emilyaunins (@CAMBUPenn), @KingOfPathogens, Anthony Phan (@PennVet), Susan Domchek (@PennCancer), @WeissmanLab (@PennMedicine), @MgAlameh (@PennPathLabMed) & @SCOTTeHENSLEY (@PennMicro) @SciImmunology
https://t.co/MO8IDNdGA8
0
6
17
🏆 Being a former #BIALAwardinBiomedicine winning author, and a Nobel Prize winner, Drew Weissman, from @WeissmanLab, recognises the importance of this award, leaving some considerations for those who can nominate: ✅ Identify an important work, ✅ With relevance to the field
0
1
3
Researchers crack the code of body’s ancient immune defense @raviradhak @PennEngineers @pennbioeng @Penn
https://t.co/u8G4iTeMj7
penntoday.upenn.edu
A collaborative team from Penn Medicine and Penn Engineering have unraveled the mathematics of a 500-million-year-old protein network that “decides” which foreign materials are friend or foe.
0
0
1